Shanghai INT Medical Instruments Co., Ltd. (HKG:1501)

Hong Kong · Delayed Price · Currency is HKD

29.96

-0.22 (-0.73%)

Oct 23, 2026, 3:59 PM HKT

Market Cap	6.33B +16.7%
Revenue (ttm)	1.39B +30.4%
Net Income	251.99M +21.4%
EPS	1.41 +11.8%
Shares Out	211.20M
PE Ratio	21.31
Forward PE	n/a
Dividend	0.26 (0.87%)
Ex-Dividend Date	Jun 3, 2026

Volume	171,200
Open	30.40
Previous Close	30.18
Day's Range	29.42 - 30.40
52-Week Range	27.86 - 41.40
Beta	0.03
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 24, 2026

About HKG:1501

Shanghai INT Medical Instruments Co., Ltd., together with its subsidiaries, engages in the research and development, manufacture, and sale of cardiovascular interventional medical devices in Mainland China, Europe, the United States, and internationally. It offers transradial and femoral pressure bandage, hydrophilic guidewire, pressure Y-connector set, PTFE guidewire, PTCA balloon dilatation catheter, noncompliant balloon dilatation catheter, compression femoral artery tourniquet, vascular sheaths for single use, push-to-thread balloon dilatio... [Read more]

Industry Medical Instruments & Supplies

Sector Healthcare

Founded 2006

Employees 2,180

Stock Exchange Hong Kong Stock Exchange

Ticker Symbol 1501

Full Company Profile

Financial Performance

In 2025, HKG:1501's revenue was 1.07 billion, an increase of 25.06% compared to the previous year's 851.95 million. Earnings were 206.23 million, an increase of 13.99%.

Financial numbers in CNY Financial Statements